Eloxx Pharmaceuticals, Inc. (ELOX)
15.51
-0.20
(-1.27%)
USD |
OTCM |
Oct 02, 16:00
15.32
-0.19
(-1.23%)
After-Hours: 20:00
Eloxx Pharmaceuticals Enterprise Value : 0.6386M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.6386M |
| October 01, 2026 | 1.446M |
| September 30, 2026 | -0.1687M |
| September 29, 2026 | 0.2753M |
| September 28, 2026 | -1.42M |
| September 25, 2026 | -1.299M |
| September 24, 2026 | 2.616M |
| September 23, 2026 | 0.3358M |
| September 22, 2026 | 5.563M |
| September 21, 2026 | 7.420M |
| September 18, 2026 | 8.469M |
| September 17, 2026 | 8.873M |
| September 16, 2026 | 9.196M |
| September 15, 2026 | 11.70M |
| September 14, 2026 | 3.827M |
| September 11, 2026 | 1.607M |
| September 10, 2026 | 3.747M |
| September 09, 2026 | 4.917M |
| September 08, 2026 | 3.303M |
| September 04, 2026 | -1.42M |
| September 03, 2026 | -4.690M |
| September 02, 2026 | 1.971M |
| September 01, 2026 | -1.380M |
| August 31, 2026 | 5.724M |
| August 28, 2026 | -1.138M |
| Date | Value |
|---|---|
| August 27, 2026 | 2.616M |
| August 26, 2026 | 12.83M |
| August 25, 2026 | 15.90M |
| August 24, 2026 | 18.72M |
| August 21, 2026 | 22.70M |
| August 20, 2026 | 10.85M |
| August 19, 2026 | 11.31M |
| August 18, 2026 | 11.70M |
| August 17, 2026 | 12.59M |
| August 14, 2026 | 13.76M |
| August 13, 2026 | 15.01M |
| August 12, 2026 | 11.76M |
| August 11, 2026 | 15.45M |
| August 10, 2026 | 6.653M |
| August 07, 2026 | 8.954M |
| August 06, 2026 | 9.519M |
| August 05, 2026 | 10.20M |
| August 04, 2026 | 12.42M |
| August 03, 2026 | 12.51M |
| July 31, 2026 | 8.388M |
| July 30, 2026 | -8.282M |
| July 29, 2026 | -12.56M |
| July 28, 2026 | -10.26M |
| July 27, 2026 | -13.09M |
| July 24, 2026 | -13.77M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Filana Therapeutics, Inc. | -37.71M |
| CorMedix, Inc. | 446.23M |
| BioStem Technologies, Inc. | 42.91M |
| Wave Life Sciences, Inc. | 283.58M |
| Axsome Therapeutics, Inc. | 9.280B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.502M |
| Total Expenses (Quarterly) | 4.502M |
| EPS Diluted (Quarterly) | -0.6631 |
| Earnings Yield | -53.36% |
| Normalized Earnings Yield | -53.79 |